Data-Driven Decision Making

Cosmetics brand Sorevna is diving into the crowded bath and body sector, promising a revolutionary launch. But can its science-first approach succeed?

The deal completes insitro’s TherML platform, integrating physics-informed AI to design better drugs faster by solving efficacy and manufacturing hurdles at once.

Serenity Mental Health Centers expands its advanced, non-medication depression treatment in Nocatee, addressing a critical need in the growing community.

With a new brand and website, DOAR consolidates its expert, jury, and trial consulting services, reflecting a major shift in the legal support industry.

Manas AI gains unique access to Schrödinger's physics platform, uniting top minds and tech to slash drug development timelines. Is this the future?

NYU Langone and tech firm Tempus are launching a new protocol using serial DNA sequencing and AI to create hyper-personalized cancer treatments.

ConcertAI and Foundation Medicine unite to create a huge dataset of 500k patients, using AI to accelerate the hunt for new life-saving cancer drugs.

WindRose and Francisco Partners invest in Avalon, signaling a major shift toward tech-driven management of the multi-billion dollar diagnostic testing market.

FIS finalizes its $12B acquisition of Global Payments' issuer arm and sells its Worldpay stake, creating a new data-driven force in banking tech.

A new AI-driven trading platform promises higher returns, but it enters a landscape grappling with technological risks and regulatory scrutiny.

The food services giant is the only company in its sector to earn CDP's top climate rating, signaling a major shift in industry sustainability standards.

A new prop trading firm launches with an innovative model and a veteran leader. But Brian Ferdinand's recent personal bankruptcy adds a layer of risk.

With drug costs soaring, industry veteran Ritu Malhotra joins Illuminate Rx, promising to disrupt the opaque PBM market. But can transparency truly win?

Meta's historic nuclear energy purchase signals a major shift in Big Tech's strategy to meet soaring AI power demands and reshape the US energy grid.

With a new board appointment and $19M in funding, Enhanced Genomics is leveraging its 3D genomics platform to build its own pipeline of precision therapies.

An expanded partnership aims to create next-gen cancer therapies by combining bispecific antibodies with two distinct drugs to overcome tumor resistance.

Sanofi deepens its AI partnership with CytoReason in a $16M deal, signaling a major shift in using predictive models to accelerate immunology breakthroughs.

With blockbuster preliminary sales and rapid patient adoption, Liquidia's new inhaled therapy is challenging established players in the lung disease space.

Guggenheim Investments' new $250M vehicle, backed by LGT Capital Partners, highlights the strategic depth and enduring allure of the private credit market.

As ENvue Medical prepares to ring the Nasdaq bell, a look at how its non-invasive tech for tube placement and pain relief is shaking up the MedTech world.